| Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 1721 | 2020 |
| Sinai Immunology Review Project. Immunology of COVID-19: current state of the science N Vabret, GJ Britton, C Gruber, S Hegde, J Kim, M Kuksin, R Levantovsky, ... Immunity 52 (6), 910-941, 2020 | 271 | 2020 |
| Global cancer transcriptome quantifies repeat element polarization between immunotherapy responsive and T cell suppressive classes A Solovyov, N Vabret, KS Arora, A Snyder, SA Funt, DF Bajorin, ... Cell reports 23 (2), 512-521, 2018 | 94 | 2018 |
| Sensing microbial RNA in the cytosol N Vabret, JM Blander Frontiers in immunology 4, 468, 2013 | 60 | 2013 |
| Advancing scientific knowledge in times of pandemics N Vabret, R Samstein, N Fernandez, M Merad, ... Nature Reviews Immunology 20 (6), 338-338, 2020 | 54 | 2020 |
| SARS-CoV-2: the many pros of targeting PLpro CB McClain, N Vabret Signal Transduction and Targeted Therapy 5 (1), 223, 2020 | 51 | 2020 |
| Sequence-specific sensing of nucleic acids N Vabret, N Bhardwaj, BD Greenbaum Trends in immunology 38 (1), 53-65, 2017 | 49 | 2017 |
| The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicity N Vabret, M Bailly-Bechet, V Najburg, M Müller-Trutwin, B Verrier, ... PloS one 7 (4), e33502, 2012 | 42 | 2012 |
| Sinai immunology review project; trainees; faculty. Advancing scientific knowledge in times of pandemics N Vabret, R Samstein, N Fernandez, M Merad Nat. Rev. Immunol 20 (338), 10.1038, 2020 | 35 | 2020 |
| Antibody responses to SARS-CoV-2 short-lived N Vabret Nature Reviews Immunology 20 (9), 519-519, 2020 | 33 | 2020 |
| Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro N Vabret, M Bailly-Bechet, A Lepelley, V Najburg, O Schwartz, B Verrier, ... Journal of virology 88 (8), 4161-4172, 2014 | 26 | 2014 |
| Identification of RNA partners of viral proteins in infected cells AV Komarova, C Combredet, O Sismeiro, MA Dillies, B Jagla, ... RNA biology 10 (6), 943-956, 2013 | 21 | 2013 |
| Dark genome, bright ideas: recent approaches to harness transposable elements in immunotherapies AR Cahn, N Bhardwaj, N Vabret Cancer Cell 40 (8), 792-797, 2022 | 14 | 2022 |
| Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1 N Vabret, V Najburg, A Solovyov, R Gopal, C McClain, P Šulc, S Balan, ... Iscience 25 (7), 2022 | 14 | 2022 |
| Preclinical data from SARS-CoV-2 mRNA vaccine N Vabret Nature Reviews Immunology 20 (8), 461-461, 2020 | 12 | 2020 |
| Innate immune system activation by viral RNA: How to predict it? M Kondili, M Roux, N Vabret, M Bailly-Bechet Virology 488, 169-178, 2016 | 11 | 2016 |
| Y-RNAs lead an endogenous program of RIG-I agonism mobilized upon RNA virus infection and targeted by HIV N Vabret, V Najburg, A Solovyov, P Šulc, S Balan, G Beauclair, M Chazal, ... bioRxiv, 773820, 2019 | 9 | 2019 |
| Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010 S Brinckmann, K Da Costa, MJ van Gils, D Hallengärd, K Klein, L Madeira, ... Journal of translational medicine 9, 1-12, 2011 | 8 | 2011 |
| Repeats mimic immunostimulatory viral features across a vast evolutionary landscape P Šulc, A Di Gioacchino, A Solovyov, SA Marhon, S Sun, HT Lindholm, ... | 7 | 2023 |
| Repeat elements amplify TLR signaling T O’Donnell, N Vabret Nature Reviews Immunology 21 (12), 760-760, 2021 | 7 | 2021 |
